Adendra Therapeutics

Recent Finacing

Series A

Recent Raise

$53M

Adendra is a Francis Crick Institute biotech spinout developing dendritic cell–targeting immunotherapies that modulate antigen presentation to adaptive T cells for treating solid tumors and T‑cell–mediated autoimmune diseases.